Ozge Gumusay
Acibadem, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Immune-related adverse events as predictors of pathological complete response in early-stage triple-negative breast cancer treated with pembrolizumab.
Journal: Immunotherapy
Published: April 21, 2026
Expectations and experiences of yoga in women with breast cancer receiving endocrine therapy: a qualitative study.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: March 06, 2026
Beyond CDK4/6 Inhibition: Current Strategies in Hormone Receptor-Positive Metastatic Breast Cancer.
Journal: Current treatment options in oncology
Published: October 19, 2025
Causes of diagnostic and treatment delays in locally advanced breast cancer: a nationwide multicenter survey and electronic health records analysis in Turkiye.
Journal: European journal of public health
Published: July 08, 2025
Activity of CDK4/6 inhibitors and parameters affecting survival in elderly patients in age-subgroups: Turkish Oncology Group (TOG) retrospective study.
Journal: BMC cancer
Published: August 03, 2024
Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.
Journal: Clinical breast cancer
Published: June 29, 2024
Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study.
Journal: Journal of chemotherapy (Florence, Italy)
Published: June 21, 2024
PD-1 and PD-L1 Blockade plus Chemotherapy in Endometrial Cancer.
Journal: The New England journal of medicine
Published: August 30, 2023
Adrenocortical Cancer in the Real World: A Comprehensive Analysis of Clinical Features and Management from the Turkish Oncology Group (TOG).
Journal: Clinical genitourinary cancer
Published: August 27, 2023
Advancing immunotherapy in gastroesophageal cancer through rational combinations and biomarkers.
Journal: Immunotherapy
Published: June 09, 2023
Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer.
Journal: Future oncology (London, England)
Published: May 03, 2023
A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancer.
Journal: Breast cancer research and treatment
Published: April 10, 2023
Last Updated: 09/26/2026